Researchers develop tool that reduces errors in stem cell transplant reporting

by Children's Hospital of PhiladelphiaCredit: CC0 Public DomainResearchers at Children's Hospital of Philadelphia (CHOP) have developed a custom-built application to automate determinatio

Updated on: February 20,2024

Researchers develop tool that reduces errors in stem cell transplant reporting

by Children's Hospital of PhiladelphiaCredit: CC0 Public DomainResearchers at Children's Hospital of Philadelphia (CHOP) have developed a custom-built application to automate determinatio

Updated on:February 20,2024

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainTriple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with th

Updated on: January 02,2024

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainTriple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with th

Updated on:January 02,2024

Tumors backfire on chemotherapy

by Ecole Polytechnique Federale de LausanneEndothelial cells (blue/grey) internalizing exosomes (red) released from chemotherapy-treated tumors. Credit: C. Cianciaruso/I. Keklikoglou/EPFLSome pat

Updated on: April 07,2024

Tumors backfire on chemotherapy

by Ecole Polytechnique Federale de LausanneEndothelial cells (blue/grey) internalizing exosomes (red) released from chemotherapy-treated tumors. Credit: C. Cianciaruso/I. Keklikoglou/EPFLSome pat

Updated on:April 07,2024

Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouragin

Updated on: January 15,2024

Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouragin

Updated on:January 15,2024

Researchers accurately predict how well body will fight lung cancer based on patterns of immune cells

by Case Western Reserve UniversityActual photographs of the shape of the cancer-associated immune cells. Credit: Case Western Reserve UniversityResearchers at Case Western Reserve University have

Updated on: March 01,2024

Researchers accurately predict how well body will fight lung cancer based on patterns of immune cells

by Case Western Reserve UniversityActual photographs of the shape of the cancer-associated immune cells. Credit: Case Western Reserve UniversityResearchers at Case Western Reserve University have

Updated on:March 01,2024

Vitamin D supplementation likely improves survival of cancers of the digestive tract, says researcher

by Boston University School of MedicineCredit: Unsplash/CC0 Public DomainFor more than 100 years, it has been believed that sunlight and vitamin D deficiency were associated with the risk for man

Updated on: January 30,2024

Vitamin D supplementation likely improves survival of cancers of the digestive tract, says researcher

by Boston University School of MedicineCredit: Unsplash/CC0 Public DomainFor more than 100 years, it has been believed that sunlight and vitamin D deficiency were associated with the risk for man

Updated on:January 30,2024

Study finds Black patients wait longer for uterine cancer testing, diagnosis

by Mallory Locklear,Yale UniversityCredit: Unsplash/CC0 Public DomainEarly diagnosis of uterine cancer is known to improve a patient's chances for survival, but previous research has found t

Updated on: February 18,2024

Study finds Black patients wait longer for uterine cancer testing, diagnosis

by Mallory Locklear,Yale UniversityCredit: Unsplash/CC0 Public DomainEarly diagnosis of uterine cancer is known to improve a patient's chances for survival, but previous research has found t

Updated on:February 18,2024

Costs of $259,324 incurred by adolescent, young adult cancer survivors

by Elana GotkineAdolescent and young adult (AYA) cancer survivors incur costs of $259,324 over their lifetime, according to a study published online Feb. 24 in theJournal of Clinical Oncology.Su

Updated on: January 02,2024

Costs of $259,324 incurred by adolescent, young adult cancer survivors

by Elana GotkineAdolescent and young adult (AYA) cancer survivors incur costs of $259,324 over their lifetime, according to a study published online Feb. 24 in theJournal of Clinical Oncology.Su

Updated on:January 02,2024

COVID-19 pandemic halted breast cancer screenings for many, finds study

by Andrew J. Yawn,Tulane UniversityCredit: Unsplash/CC0 Public DomainThe COVID-19 pandemic significantly disrupted routine medical checks for many.A new study from Tulane University has found th

Updated on: January 23,2024

COVID-19 pandemic halted breast cancer screenings for many, finds study

by Andrew J. Yawn,Tulane UniversityCredit: Unsplash/CC0 Public DomainThe COVID-19 pandemic significantly disrupted routine medical checks for many.A new study from Tulane University has found th

Updated on:January 23,2024

One sigmoidoscopy significantly reduces long-term CRC incidence in both men and women

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA pooled analysis evaluating the 15-year effect of sigmoidoscopies has found that receiving one sigmoidoscopy significantly reduc

Updated on: January 30,2024

One sigmoidoscopy significantly reduces long-term CRC incidence in both men and women

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA pooled analysis evaluating the 15-year effect of sigmoidoscopies has found that receiving one sigmoidoscopy significantly reduc

Updated on:January 30,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on: January 30,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on:January 30,2024

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on: June 04,2024

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on:June 04,2024